The effects of weight loss on FABP4 and RBP4 in obese women with metabolic syndrome

Hormone and Metabolic Research

Volumn 46, Issue 3, 2014, Pages 224-231

  Comerford, K B ^a   Buchan, W ^b   Karakas, S E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

adipokines; insulin resistance; weight loss

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FASTING GLUCOSE; FASTING INSULIN; FATTY ACID BINDING PROTEIN 4; FETUIN A; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; CALORIMETRY; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS LOSS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LEAN MASS LOSS; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MIDDLE AGED; MISCELLANEOUS NAMED GROUPS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESE WOMAN; OUTCOME ASSESSMENT; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTING ENERGY EXPENDITURE; RISK ASSESSMENT; RISK FACTOR; SUBSTRATE OXIDATION; TRIACYLGLYCEROL BLOOD LEVEL; TRUNK FAT; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; YOUNG ADULT;

ADULT; ANTHROPOMETRY; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; REGRESSION ANALYSIS; RETINOL-BINDING PROTEINS, PLASMA; WEIGHT LOSS;

EID: 84895518625     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1353204     Document Type: Article

References (40)

1. Martens F. M., Visseren F. L. The operative risk factors in the metabolic syndrome: is it lipids and high BP or are there direct vascular effects of insulin resistance and obesity. Curr Diab Rep: 2007; 7 74 81
2. Wassink A. M., Olijhoek J. K., Visseren F. L. The metabolic syndrome: metabolic changes with vascular consequences. Eur J Clin Invest: 2007; 37 8 17
3. Xu A., Wang Y., Xu J. Y., Stejskal D., Tam S., Zhang J., Wat N. M., Wong W. K., Lam K. S. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem: 2006; 52 405 413
4. Stejskal D., Karpisek M. Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest: 2006; 36 621 625
5. Chiba M., Saitoh S., Ohnishi H., Akasaka H., Mitsumata K., Furukawa T., Shimamoto K. Associations of metabolic factors, especially serum retinol-binding protein 4 (RBP4), with blood pressure in Japanese - the Tanno and Sobetsu study. Endocr J: 2010; 57 811 817
6. van Hoek M., Dehghan A., Zillikens M. C., Hofman A., Witteman J. C., Sijbrands E. J. An RBP4 promoter polymorphism increases risk of type 2 diabetes. Diabetologia: 2008; 51 1423 1428
7. Lin C. C., Lai M. M., Li T. C., Li C. I., Liu C. S., Chen C. C., Wu M. T. Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome. Diabetes Res Clin Pract: 2009; 85 24 29
8. Jenkins-Kruchten A. E., Bennaars-Eiden A., Ross J. R., Shen W. J., Kraemer F. B., Bernlohr D. A. Fatty acid-binding protein-hormone-sensitive lipase interaction. Fatty acid dependence on binding. J Biol Chem: 2003; 278 47636 47643
9. Shen W. J., Liang Y., Hong R., Patel S., Natu V., Sridhar K., Jenkins A., Bernlohr D. A., Kraemer F. B. Characterization of the functional interaction of adipocyte lipid-binding protein with hormone-sensitive lipase. J Biol Chem: 2001; 276 49443 49448
10. Karakas S. E., Almario R. U., Kim K. Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers. Metabolism: 2009; 58 1002 1007
11. Haider D. G., Schindler K., Bohdjalian A., Prager G., Luger A., Wolzt M., Ludvik B. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab: 2007; 9 761 763
12. Reinehr T., Stoffel-Wagner B., Roth C. L. Adipocyte fatty acid-binding protein in obese children before and after weight loss. Metabolism: 2007; 56 1735 1741
13. Bahr M. J., Boeker K. H., Manns M. P., Tietge U. J. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis. Clin Endocrinol (Oxf): 2009; 70 60 65
14. Wolf G. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutr Rev: 2007; 65 251 256
15. Schina M., Koskinas J., Tiniakos D., Hadziyannis E., Savvas S., Karamanos B., Manesis E., Archimandritis A. Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease. Hepatol Res: 2009; 39 972 978
16. Comerford K. B., Almario R. U., Kim K., Karakas S. E. Lean mass and insulin resistance in women with polycystic ovary syndrome. Metabolism: clinical and experimental: 2012; 61 1256 1260
17. Tamori Y., Sakaue H., Kasuga M. RBP4, an unexpected adipokine. Nat Med: 2006; 12 30 31 discussion 31
18. Tajtakova M., Semanova Z., Ivancova G., Petrovicova J., Donicova V., Zemberova E. Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin. Vnitr Lek: 2007; 53 960 963
19. Pfutzner A., Schondorf T., Hanefeld M., Lubben G., Kann P. H., Karagiannis E., Wilhelm B., Forst T. Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients. Horm Metab Res: 2009; 41 202 206
20. Graham T. E., Yang Q., Bluher M., Hammarstedt A., Ciaraldi T. P., Henry R. R., Wason C. J., Oberbach A., Jansson P. A., Smith U., Kahn B. B. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med: 2006; 354 2552 2563
21. Yao-Borengasser A., Varma V., Bodles A. M., Rasouli N., Phanavanh B., Lee M. J., Starks T., Kern L. M., Spencer H. J. 3rd, Rashidi A. A., McGehee R. E. Jr, Fried S. K., Kern P. A. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. The Journal of clinical endocrinology and metabolism: 2007; 92 2590 2597
22. Baudry A., Lamothe B., Bucchini D., Jami J., Montarras D., Pinset C., Joshi R. L. IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells. FEBS Lett: 2001; 488 174 178
23. Yang Q., Graham T. E., Mody N., Preitner F., Peroni O. D., Zabolotny J. M., Kotani K., Quadro L., Kahn B. B. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature: 2005; 436 356 362
24. Haider D. G., Schindler K., Prager G., Bohdjalian A., Luger A., Wolzt M., Ludvik B. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. The J Clin Endocrinol Metab: 2007; 92 1168 1171
25. Corripio R., Gonzalez-Clemente J. M., Perez-Sanchez J., Naf S., Gallart L., Nosas R., Vendrell J., Caixas A. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study. Eur J Endocrinol: 2010; 163 887 893
26. Queipo-Ortuno M. I., Escote X., Ceperuelo-Mallafre V., Garrido-Sanchez L., Miranda M., Clemente-Postigo M., Perez-Perez R., Peral B., Cardona F., Fernandez-Real J. M., Tinahones F. J., Vendrell J. FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels. PLoS One: 2012; 7 e48605
27. Roca-Rivada A., Castelao C., Senin L. L., Landrove M. O., Baltar J., Crujeiras A. B., Seoane L. M., Casanueva F. F., Pardo M. FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine. PLoS One: 2013; 8 e60563
28. Engeli S., Utz W., Haufe S., Lamounier-Zepter V., Pofahl M., Traber J., Janke J., Luft F. C., Boschmann M., Schulz-Menger J., Jordan J. Fatty acid binding protein 4 predicts left ventricular mass and longitudinal function in overweight and obese women. Heart: 2013; 99 944 948
29. Cabre A., Valdovinos P., Lazaro I., Bonet G., Bardaji A., Masana L. Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients. Cardiovasc Diabetol: 2013; 12 72
30. Gomez-Ambrosi J., Rodriguez A., Catalan V., Ramirez B., Silva C., Rotellar F., Gil M. J., Salvador J., Fruhbeck G. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Clin Endocrinol (Oxf): 2008; 69 208 215
31. Balagopal P., Graham T. E., Kahn B. B., Altomare A., Funanage V., George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. The Journal of clinical endocrinology and metabolism: 2007; 92 1971 1974
32. Ku Y. H., Han K. A., Ahn H., Kwon H., Koo B. K., Kim H. C., Min K. W. Resistance exercise did not alter intramuscular adipose tissue but reduced retinol-binding protein-4 concentration in individuals with type 2 diabetes mellitus. J Int Med Res: 2010; 38 782 791
33. Lim S., Choi S. H., Jeong I. K., Kim J. H., Moon M. K., Park K. S., Lee H. K., Kim Y. B., Jang H. C. Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women. The Journal of clinical endocrinology and metabolism: 2008; 93 2263 2268
34. Choi K. M., Kim T. N., Yoo H. J., Lee K. W., Cho G. J., Hwang T. G., Baik S. H., Choi D. S., Kim S. M. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clin Endocrinol (Oxf): 2009; 70 569 574
35. Nair A. K., Sugunan D., Kumar H., Anilkumar G. Case-control analysis of SNPs in GLUT4, RBP4 and STRA6: association of SNPs in STRA6 with type 2 diabetes in a South Indian population. PLoS One: 2010; 5 e11444
36. Khovidhunkit W., Pruksakorn P., Plengpanich W., Tharavanij T. Retinol-binding protein 4 is not associated with insulin resistance in pregnancy. Metabolism: 2012; 61 65 69
37. Lewis J. G., Shand B. I., Elder P. A., Scott R. S. Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance. Diabetes Res Clin Pract: 2008; 80 e13 e15
38. Sopher A. B., Gerken A. T., Lee E. J., Blaner W. E., Deeds S., Gallagher D., Shungu D. C., Mao X., Hassoun A., Mahon D. J., Oberfield S. E. Retinol-binding protein 4 correlates with triglycerides but not insulin resistance in prepubertal children with and without premature adrenarche. J Pediatr Endocrinol Metab: 2011; 24 683 687
39. Al-Daghri N. M., Al-Attas O. S., Alokail M., Draz H. M., Bamakhramah A., Sabico S. Retinol binding protein-4 is associated with TNF-alpha and not insulin resistance in subjects with type 2 diabetes mellitus and coronary heart disease. Dis Markers: 2009; 26 135 140
40. McInnes K. J., Smith L. B., Hunger N. I., Saunders P. T., Andrew R., Walker B. R. Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis. Diabetes: 2012; 61 1072 1081